Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket

9/16/2026
Impact: 50
Healthcare

Tempest Therapeutics Inc (NASDAQ: TPST) shares increased by 49.6% to $1.13 in pre-market trading following the announcement of an exclusive option agreement with Hebei Senlang Biotechnology Co., Ltd. This agreement allows Tempest to license Senlang's CD7-targeted lentiviral vector platform and its in vivo CAR-T pipeline, which includes a candidate in Phase 1 trials for relapsed or refractory multiple myeloma.

AI summary, not financial advice

Share: